List of Excipients in API DIFLUNISAL
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing DIFLUNISAL
Detailed excipient profiles for DIFLUNISAL
Excipient focus: CELLULOSE, MICROCRYSTALLINE
DIFLUNISAL drug variants containing CELLULOSE, MICROCRYSTALLINE
DIFLUNISAL drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
DIFLUNISAL drug variants containing CROSCARMELLOSE SODIUM
DIFLUNISAL drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2
DIFLUNISAL drug variants containing FD&C BLUE NO. 2
DIFLUNISAL drug variants not containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | diflunisal | 0093-0755 |
| Teva Pharmaceuticals USA Inc | diflunisal | 0093-9222 |
| INA Pharmaceutics Inc | diflunisal | 74157-009 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2 ALUMINUM LAKE
DIFLUNISAL drug variants containing FD&C BLUE NO. 2 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| INA Pharmaceutics Inc | diflunisal | 74157-009 |
| >Company | >Ingredient | >NDC |
DIFLUNISAL drug variants not containing FD&C BLUE NO. 2 ALUMINUM LAKE
Excipient focus: FD&C BLUE NO. 2--ALUMINUM LAKE
DIFLUNISAL drug variants containing FD&C BLUE NO. 2--ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | diflunisal | 0093-0755 |
| Teva Pharmaceuticals USA Inc | diflunisal | 0093-9222 |
| >Company | >Ingredient | >NDC |
DIFLUNISAL drug variants not containing FD&C BLUE NO. 2--ALUMINUM LAKE
Excipient focus: FD&C YELLOW NO. 6
DIFLUNISAL drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Pharmaceuticals (USA) Inc | diflunisal | 68382-530 |
| Zydus Lifesciences Limited | diflunisal | 70771-1083 |
| >Company | >Ingredient | >NDC |
DIFLUNISAL drug variants not containing FD&C YELLOW NO. 6
Excipient focus: HYPROMELLOSE
DIFLUNISAL drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| INA Pharmaceutics Inc | diflunisal | 74157-009 |
| >Company | >Ingredient | >NDC |
DIFLUNISAL drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2910
DIFLUNISAL drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | diflunisal | 0093-0755 |
| Teva Pharmaceuticals USA Inc | diflunisal | 0093-9222 |
| H J Harkins Company Inc | diflunisal | 52959-379 |
| St Mary's Medical Park Pharmacy | diflunisal | 60760-756 |
| Carilion Materials Management | diflunisal | 68151-0848 |
| >Company | >Ingredient | >NDC |
DIFLUNISAL drug variants not containing HYPROMELLOSE 2910
Excipient focus: HYPROMELLOSES
DIFLUNISAL drug variants containing HYPROMELLOSES
DIFLUNISAL drug variants not containing HYPROMELLOSES
Excipient focus: INDIGOTINDISULFONATE SODIUM
DIFLUNISAL drug variants containing INDIGOTINDISULFONATE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| H J Harkins Company Inc | diflunisal | 52959-379 |
| St Mary's Medical Park Pharmacy | diflunisal | 60760-756 |
| Carilion Materials Management | diflunisal | 68151-0848 |
| >Company | >Ingredient | >NDC |
DIFLUNISAL drug variants not containing INDIGOTINDISULFONATE SODIUM
Excipient focus: POLYETHYLENE GLYCOL 400
DIFLUNISAL drug variants containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Pharmaceuticals (USA) Inc | diflunisal | 68382-530 |
| Zydus Lifesciences Limited | diflunisal | 70771-1083 |
| >Company | >Ingredient | >NDC |
DIFLUNISAL drug variants not containing POLYETHYLENE GLYCOL 400
Excipient focus: PROPYLENE GLYCOL
DIFLUNISAL drug variants containing PROPYLENE GLYCOL
DIFLUNISAL drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Pharmaceuticals (USA) Inc | diflunisal | 68382-530 |
| Zydus Lifesciences Limited | diflunisal | 70771-1083 |
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
DIFLUNISAL drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Pharmaceuticals (USA) Inc | diflunisal | 68382-530 |
| Zydus Lifesciences Limited | diflunisal | 70771-1083 |
| >Company | >Ingredient | >NDC |
DIFLUNISAL drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM STEARYL FUMARATE
DIFLUNISAL drug variants containing SODIUM STEARYL FUMARATE
DIFLUNISAL drug variants not containing SODIUM STEARYL FUMARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
DIFLUNISAL drug variants containing STARCH, CORN
DIFLUNISAL drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
DIFLUNISAL drug variants containing TITANIUM DIOXIDE
DIFLUNISAL drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
